We are live on
!
Find out more
VCG
Vantage Consulting Group Portfolio holdings
AUM
$19.7M
1-Year Est. Return
280.87%
This Fund
S&P 500
This Quarter
Est. Return
+17.65%
1 Year Est. Return
+280.87%
3 Year Est. Return
+261.08%
5 Year Est. Return
+180.34%
10 Year Est. Return
–
AUM
$1.23B
AUM Growth
–
Cap. Flow
+$1.06B
Cap. Flow
% of AUM
86.51%
Top 10 Holdings %
Top 10 Hldgs %
94.5%
Holding
1,884
New
1,883
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$911M |
| 2 |
ADC Therapeutics
ADCT
|
+$55.1M |
| 3 |
KYNB
Kyntra Bio
KYNB
|
+$25.5M |
| 4 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$5.96M |
| 5 |
Kroger
KR
|
+$366K |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 95.04% |
| 2 | Technology | 0.89% |
| 3 | Consumer Discretionary | 0.79% |
| 4 | Industrials | 0.61% |
| 5 | Consumer Staples | 0.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CCMP
726
DELISTED
CMC Materials, Inc. Common Stock
CCMP
| $28K | ﹤0.01% |
+182
| New | +$27.3K |
|
727
Anika Therapeutics
ANIK
$277M
| $27K | ﹤0.01% |
+590
| New | +$22.4K |
|
728
B&G Foods
BGS
$290M
| $27K | ﹤0.01% |
+966
| New | +$27.2K |
|
729
Community Bank
CBU
$3.5B
| $27K | ﹤0.01% |
+438
| New | +$26.9K |
|
730
Crown Castle
CCI
$33.5B
| $27K | ﹤0.01% |
+171
| New | +$27.7K |
|
731
Citizens Financial Group
CFG
$30.7B
| $27K | ﹤0.01% |
+743
| New | +$23.3K |
|
732
Ezcorp Inc
EZPW
$1.86B
| $27K | ﹤0.01% |
+5,552
| New | +$27.9K |
|
|
FITB
733
Fifth Third Bancorp
FITB
$51.6B
| $27K | ﹤0.01% |
+964
| New | +$24.3K |
|
734
Green Plains
GPRE
$1.17B
| $27K | ﹤0.01% |
+2,046
| New | +$31.1K |
|
735
Innoviva
INVA
$1.53B
| $27K | ﹤0.01% |
+2,143
| New | +$23.1K |
|
736
KeyCorp
KEY
$24.5B
| $27K | ﹤0.01% |
+1,660
| New | +$24.2K |
|
737
Prologis
PLD
$135B
| $27K | ﹤0.01% |
+270
| New | +$27.3K |
|
738
PNC Financial Services
PNC
$100B
| $27K | ﹤0.01% |
+181
| New | +$23.1K |
|
739
Regions Financial
RF
$26.9B
| $27K | ﹤0.01% |
+1,691
| New | +$24.5K |
|
740
Truist Financial
TFC
$63.4B
| $27K | ﹤0.01% |
+558
| New | +$25.3K |
|
741
US Bancorp
USB
$99.6B
| $27K | ﹤0.01% |
+572
| New | +$24.2K |
|
742
US Physical Therapy
USPH
$1.18B
| $27K | ﹤0.01% |
+221
| New | +$22.3K |
|
743
Viasat
VSAT
$11.2B
| $27K | ﹤0.01% |
+823
| New | +$28.3K |
|
|
MIK
744
DELISTED
Michaels Stores, Inc
MIK
| $27K | ﹤0.01% |
+2,089
| New | +$21.2K |
|
745
CTS Corp
CTS
$1.86B
| $26K | ﹤0.01% |
+754
| New | +$22.3K |
|
|
CVGW
746
DELISTED
Calavo Growers
CVGW
| $26K | ﹤0.01% |
+379
| New | +$26.7K |
|
747
Energizer
ENR
$1.45B
| $26K | ﹤0.01% |
+610
| New | +$25.8K |
|
748
Diamondback Energy
FANG
$55.9B
| $26K | ﹤0.01% |
+534
| New | +$19.7K |
|
|
DMC
749
Del Monte Corp
DMC
$1.43B
| $26K | ﹤0.01% |
+1,092
| New | +$26.3K |
|
|
FISV
750
Fiserv Inc
FISV
$29B
| $26K | ﹤0.01% |
+229
| New | +$24.7K |
|
Similar funds
MVG
NCM
FFGIM
PIM
HFG
SWM
ICM
SM
Vantage Consulting Group's Q4 2020 Portfolio in Review
Q4 2020 is the first quarter with a 13F filing on record for Vantage Consulting Group, which disclosed 1,884 positions worth $1.23B. Its ten largest holdings account for 94% of the portfolio.
Its largest position is Royalty Pharma: 21,477,282 shares worth $1.07B.
By sector, the portfolio is most concentrated in Healthcare at 95% of assets, followed by Technology and Consumer Discretionary.
- Vantage Consulting Group's largest Q4 2020 buy was Royalty Pharma: 21,477,282 shares worth $1.07B.
- Vantage Consulting Group's ten largest holdings make up 94% of its $1.23B portfolio in Q4 2020.
- Vantage Consulting Group disclosed 1,884 positions in Q4 2020, its first 13F filing on record.
Based on Vantage Consulting Group's 13F filing for Q4 2020, filed 12 Feb 2021.